The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
Abstract
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that results from the accumulation of lipoproteinaceous material in the alveoli and alveolar macrophages due to abnormal surfactant homoeostasis. Identification of the granulocyte-macrophage colony-stimulating factor (GM-CSF) as an indispensable mediator of macrophage maturation and surfactant catabolism was the key discovery leading to the current understanding of the pathogenesis of most forms of PAP. Impaired GM-CSF bioavailability due to anti-GM-CSF autoimmunity is the cause of approximately 90% of adult PAP cases. Abnormal macrophage function due to endogenous or exogenous triggers, GM-CSF receptor defects, and other genetic abnormalities of surfactant production account for the remainder of causes. The usual physiological consequence of PAP is impairment of gas exchange, which can lead to dyspnoea, hypoxaemia, or even respiratory failure and death. Pulmonary fibrosis occurs occasionally in patients with PAP. For patients with moderate to severe disease, whole lung lavage is still the first-line treatment of choice. Supplemental GM-CSF is also useful, but details about indications, choice of agent, and dosing remain unclear. Other therapies, including rituximab, plasmapheresis, and lung transplantation have been described but should be reserved for refractory cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GM-CSF Regulates Bleomycin-Induced Pulmonary Fibrosis Via a Prostaglandin-Dependent Mechanism
Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4032 · Cited by 158
Pulmonary Alveolar Proteinosis and Aluminum Dust Exposure
Miller, R. R., Churg, A. M., Hutcheon, M., & Lam, S. (1984) · American Review of Respiratory Disease · doi:10.1164/arrd.1984.130.2.312 · Cited by 126
Cited by
Silica‐related diseases in the modern world
Hoy, R. F., & Chambers, D. C. (2020) · Allergy · doi:10.1111/all.14202 · Cited by 415
Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection
Aegerter, H., Kulikauskaite, J., Crotta, S., Patel, H., Kelly, G., Hessel, E. M., Mack, M., Beinke, S., & Wack, A. (2020) · Nature Immunology · doi:10.1038/s41590-019-0568-x · Cited by 356
Iron Homeostasis in the Lungs—A Balance between Health and Disease
Neves, J., Haider, T., Gassmann, M., & Muckenthaler, M. U. (2019) · Pharmaceuticals · doi:10.3390/ph12010005 · Cited by 94
Metadata
- Authors
- Kumar, A., Abdelmalak, B., Inoue, Y., & Culver, D. A.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 6
- Issue
- 7
- Pages
- 554-565
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W2787206146
- Cited by
- 182
- References
- 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. https://app.cochat.ai/papers/10.1016/s2213-2600(18)30043-2
- The paper
- Kumar, A., Abdelmalak, B., Inoue, Y., & Culver, D. A. (2018). Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(18)30043-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.